Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy

This study has been completed.
Information provided by:
Endo Pharmaceuticals Identifier:
First received: May 15, 2009
Last updated: February 12, 2010
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: June 2003 (Final data collection date for primary outcome measure)